Assignee
AERPIO THERAPEUTICS INC
US25 patents
Top patents by PatentIndex Score
USRE46592EOct 31, 2017
Human protein tyrosine phosphatase inhibitors and methods of use
AERPIO THERAPEUTICS INC25 citations97
US9795594B2Oct 24, 2017
Human protein tyrosine phosphatase inhibitors and methods of use
AERPIO THERAPEUTICS INC30 citations97
US9284285B2Mar 15, 2016
Human protein tyrosine phosphatase inhibitors and methods of use
AERPIO THERAPEUTICS INC27 citations97
US9126958B2Sep 8, 2015
Human protein tyrosine phosphatase inhibitors and methods of use
AERPIO THERAPEUTICS INC31 citations97
US8895563B2Nov 25, 2014
Human protein tyrosine phosphatase inhibitors and methods of use
AERPIO THERAPEUTICS INC35 citations97
US10329357B2Jun 25, 2019
Treatment of ocular disease
AERPIO THERAPEUTICS INC16 citations94
US10220048B2Mar 5, 2019
Compositions and methods for treating ocular diseases
AERPIO THERAPEUTICS INC19 citations94
US9949956B2Apr 24, 2018
Compounds, compositions, and methods for preventing metastasis of cancer cells
AERPIO THERAPEUTICS INC21 citations94
US9539245B2Jan 10, 2017
Combination of immunotherapies with activators of Tie-2
AERPIO THERAPEUTICS INC37 citations94
US9174950B2Nov 3, 2015
Compounds, compositions, and methods for preventing metastasis of cancer cells
AERPIO THERAPEUTICS INC32 citations94
US9096555B2Aug 4, 2015
Methods for treating vascular leak syndrome
AERPIO THERAPEUTICS INC32 citations94
US8999325B2Apr 7, 2015
Treatment of ocular disease
AERPIO THERAPEUTICS INC36 citations94
US8883832B2Nov 11, 2014
Compounds, compositions, and methods for preventing metastasis of cancer cells
AERPIO THERAPEUTICS INC38 citations94
US8846685B2Sep 30, 2014
Human protein tyrosine phosphatase inhibitors and methods of use
AERPIO THERAPEUTICS INC37 citations94
US9440963B2Sep 13, 2016
Compositions, formulations and methods for treating ocular diseases
AERPIO THERAPEUTICS INC35 citations93
US10150811B2Dec 11, 2018
Methods for treating vascular leak syndrome and cancer
AERPIO THERAPEUTICS INC15 citations92
US9926367B2Mar 27, 2018
Antibodies that bind human protein tyrosine phosphatase beta (HPTPbeta) and uses thereof
AERPIO THERAPEUTICS INC23 citations92
US9278930B2Mar 8, 2016
Methods for increasing the stabilization of hypoxia inducible factor-α
AERPIO THERAPEUTICS INC8 citations92
US8999971B2Apr 7, 2015
Methods for increasing the stabilization of hypoxia inducible factor-1 alpha
AERPIO THERAPEUTICS INC10 citations92
US8883774B2Nov 11, 2014
Methods for increasing the stabilization of hypoxia inducible factor-1 alpha
AERPIO THERAPEUTICS INC12 citations92
US10253094B2Apr 9, 2019
Antibodies that target human protein tyrosine phosphatase-beta (HPTP-beta) and methods of use thereof to treat ocular conditions
AERPIO THERAPEUTICS INC13 citations91
US9540326B2Jan 10, 2017
Prolyl hydroxylase inhibitors
AERPIO THERAPEUTICS INC5 citations84
US9994560B2Jun 12, 2018
HPTP-β inhibitors
AERPIO THERAPEUTICS INC8 citations79
US10562854B2Feb 18, 2020
Prolyl hydroxylase inhibitors
AERPIO THERAPEUTICS INC0 citations52
US9388135B2Jul 12, 2016
Process for preparing N-benzyl-3-hydroxy-4-substituted-pyridin-2-(1H)-ones
AERPIO THERAPEUTICS INC1 citations49